Cargando…
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241804/ https://www.ncbi.nlm.nih.gov/pubmed/34059947 http://dx.doi.org/10.1007/s00726-021-03006-7 |
_version_ | 1783715491783639040 |
---|---|
author | Diós, Ádám Elek, Rita Szabó, Ildikó Horváth, Szilvia Gyimesi, Judit Király, Róbert Werkstetter, Katharina Koletzko, Sibylle Fésüs, László Korponay-Szabó, Ilma R. |
author_facet | Diós, Ádám Elek, Rita Szabó, Ildikó Horváth, Szilvia Gyimesi, Judit Király, Róbert Werkstetter, Katharina Koletzko, Sibylle Fésüs, László Korponay-Szabó, Ilma R. |
author_sort | Diós, Ádám |
collection | PubMed |
description | Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin peptides. However, α-gliadin peptides, like p57-68, playing a crucial role in the T-cell response, and p31-43, a major trigger of innate responses, also contain B-cell gliadin epitopes and γ-gliadin like motifs. We aimed to identify if there are anti-gliadin-specific antibodies in CeD patients targeting the p31-43 and p57-68 peptides and to examine whether deamidation of these peptides could increase their antigenicity. We explored TG2-mediated deamidation of the p31-43 and p57-68 peptides, and investigated serum antibody reactivity toward the native and deamidated α and γ-gliadin peptides in children with confirmed CeD and in prospectively followed infants at increased risk for developing CeD. We affinity-purified antibody populations utilizing different single peptide gliadin antigens and tested their binding preferences for cross-reactivity in real-time interaction assays based on bio-layer interferometry. Our results demonstrate that there is serum reactivity toward p31-43 and p57-68 peptides, which is due to cross-reactive γ-gliadin specific antibodies. These γ-gliadin specific antibodies represent the first appearing antibody population in infancy and they dominate the serum reactivity of CeD patients even later on and without preference for deamidation. However, for the homologous epitope sequences in α-gliadins shorter than the core QPEQPFP heptapeptide, deamidation facilitates antibody recognition. These findings reveal the presence of cross-reactive antibodies in CeD patients recognizing the disease-relevant α-gliadins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00726-021-03006-7. |
format | Online Article Text |
id | pubmed-8241804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-82418042021-07-14 Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction Diós, Ádám Elek, Rita Szabó, Ildikó Horváth, Szilvia Gyimesi, Judit Király, Róbert Werkstetter, Katharina Koletzko, Sibylle Fésüs, László Korponay-Szabó, Ilma R. Amino Acids Original Article Celiac disease (CeD) is a T-cell-dependent enteropathy with autoimmune features where tissue transglutaminase (TG2)-mediated posttranslational modification of gliadin peptides has a decisive role in the pathomechanism. The humoral immune response is reported to target mainly TG2-deamidated γ-gliadin peptides. However, α-gliadin peptides, like p57-68, playing a crucial role in the T-cell response, and p31-43, a major trigger of innate responses, also contain B-cell gliadin epitopes and γ-gliadin like motifs. We aimed to identify if there are anti-gliadin-specific antibodies in CeD patients targeting the p31-43 and p57-68 peptides and to examine whether deamidation of these peptides could increase their antigenicity. We explored TG2-mediated deamidation of the p31-43 and p57-68 peptides, and investigated serum antibody reactivity toward the native and deamidated α and γ-gliadin peptides in children with confirmed CeD and in prospectively followed infants at increased risk for developing CeD. We affinity-purified antibody populations utilizing different single peptide gliadin antigens and tested their binding preferences for cross-reactivity in real-time interaction assays based on bio-layer interferometry. Our results demonstrate that there is serum reactivity toward p31-43 and p57-68 peptides, which is due to cross-reactive γ-gliadin specific antibodies. These γ-gliadin specific antibodies represent the first appearing antibody population in infancy and they dominate the serum reactivity of CeD patients even later on and without preference for deamidation. However, for the homologous epitope sequences in α-gliadins shorter than the core QPEQPFP heptapeptide, deamidation facilitates antibody recognition. These findings reveal the presence of cross-reactive antibodies in CeD patients recognizing the disease-relevant α-gliadins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00726-021-03006-7. Springer Vienna 2021-05-31 2021 /pmc/articles/PMC8241804/ /pubmed/34059947 http://dx.doi.org/10.1007/s00726-021-03006-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Diós, Ádám Elek, Rita Szabó, Ildikó Horváth, Szilvia Gyimesi, Judit Király, Róbert Werkstetter, Katharina Koletzko, Sibylle Fésüs, László Korponay-Szabó, Ilma R. Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title | Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title_full | Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title_fullStr | Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title_full_unstemmed | Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title_short | Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
title_sort | gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241804/ https://www.ncbi.nlm.nih.gov/pubmed/34059947 http://dx.doi.org/10.1007/s00726-021-03006-7 |
work_keys_str_mv | AT diosadam gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT elekrita gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT szaboildiko gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT horvathszilvia gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT gyimesijudit gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT kiralyrobert gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT werkstetterkatharina gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT koletzkosibylle gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT fesuslaszlo gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction AT korponayszaboilmar gammagliadinspecificceliacdiseaseantibodiesrecognizep3143andp5768alphagliadinpeptidesindeamidationrelatedmannerasaresultofcrossreaction |